Literature DB >> 3698008

Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors.

D Rotin, B Robinson, I F Tannock.   

Abstract

Hypoxia and an acidic environment are known to occur in regions of solid tumors and might be involved in the causation of necrosis. The viability and energy metabolism of cells in tissue culture were therefore investigated under hypoxic and/or acidic conditions. Acute exposure of Chinese hamster ovary (CHO) cells or human bladder cancer MGH-U1 cells to hypoxia plus low pH (6.5 to 6.0) was cytotoxic in a time- and pH-dependent manner; surviving fraction was reduced to approximately 10(-4) following a 6-h exposure to hypoxia at pH 6.0. There was no effect on viability when aerobic CHO cells were exposed for 6 h at pH 6.0, or when either cell line was rendered hypoxic for 6 h at pH 7.0; MGH-U1 cells showed slight sensitivity to acidic pH in air. Decrease in viability of CHO cells incubated under acid conditions was observed over the range of oxygen concentrations from 0.2 to 0.05%, similar to the range which causes change in cellular sensitivity to radiation. Glucose consumption and lactate production by both cell lines were inhibited at low pH under both aerobic and hypoxic conditions. Cellular adenosine triphosphate (ATP) levels and the energy charge [(ATP + 1/2 adenosine diphosphate)/(adenosine monophosphate + adenosine diphosphate + ATP)] of CHO cells were reduced by about 85 and 25%, respectively, after a 6-h exposure to hypoxia at pH 6.0 but were not influenced by hypoxia or acid pH alone. Inhibition of glycolysis by incubation of CHO cells under hypoxic conditions in the absence of glucose (at pH 7.0) led to a larger fall in cellular ATP and energy charge, but cell survival fell to only approximately 10(-2) at 6 h. These results demonstrate that hypoxia and an acid environment interact to cause marked toxicity. A decrease in energy charge of the cells may contribute to loss of viability, but additional mechanisms appear to be involved.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698008

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  Investigating Osteocytic Perilacunar/Canalicular Remodeling.

Authors:  Cristal S Yee; Charles A Schurman; Carter R White; Tamara Alliston
Journal:  Curr Osteoporos Rep       Date:  2019-08       Impact factor: 5.096

2.  Microscopic images of intraspheroidal pH by 1H magnetic resonance chemical shift imaging of pH sensitive indicators.

Authors:  Jose Alvarez-Pérez; Paloma Ballesteros; Sebastián Cerdán
Journal:  MAGMA       Date:  2005-11-18       Impact factor: 2.310

3.  Visualization of the pH-dependent dynamic distribution of G2A in living cells.

Authors:  Wanjun Lan; Satoshi Yamaguchi; Teruyasu Yamamoto; Shinya Yamahira; Modong Tan; Naoka Murakami; Jingyan Zhang; Motonao Nakamura; Teruyuki Nagamune
Journal:  FASEB J       Date:  2014-06-02       Impact factor: 5.191

4.  Impact of hypoxia on the metastatic potential of human prostate cancer cells.

Authors:  Yao Dai; Kyungmi Bae; Dietmar W Siemann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-02       Impact factor: 7.038

5.  Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.

Authors:  Hwai Wen Chang; Gerhard Frey; Haizhen Liu; Charles Xing; Lawrence Steinman; William J Boyle; Jay M Short
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

6.  Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes.

Authors:  M J Arends; A H McGregor; A H Wyllie
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

Review 7.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 8.  Disrupting proton dynamics and energy metabolism for cancer therapy.

Authors:  Scott K Parks; Johanna Chiche; Jacques Pouysségur
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

9.  A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin.

Authors:  Irene Brana; Alberto Ocana; Eric X Chen; Albiruni R A Razak; Christine Haines; Carol Lee; Sarah Douglas; Lisa Wang; Lillian L Siu; Ian F Tannock; Philippe L Bedard
Journal:  Invest New Drugs       Date:  2014-09-12       Impact factor: 3.850

10.  Distribution of radiolabelled monoclonal antibody Po66 after intravenous injection into nude mice bearing human lung cancer grafts.

Authors:  B Desrues; B Collet; M P Ramé; D Bourel; P Bourguet; A Martin; P Delaval; L Toujas; L Dazord
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.